Oral dyskinesia induced by fluoxetine therapy for infantile autism [1]

Pediatric Neurology

Volumn 31, Issue 1, 2004, Pages 76-

  Albertini, Giorgio ^a   Majolini, Lucia ^a   Di Gennaro, Giancarlo ^b   Quarato, Pier ^b   Scoppetta, Ciriaco ^c   Onorati, Paolo ^c  

^a S Raffaele Pisana Tosinvest San   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ANAMNESIS; APGAR SCORE; BEHAVIOR; CLINICAL FEATURE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; DYSKINESIA; GENETIC SCREENING; HOSPITALIZATION; HUMAN; INFANT; INFANTILE AUTISM; KARYOTYPING; LABORATORY TEST; LANGUAGE; LETTER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SIDE EFFECT; SOCIAL ASPECT; TREATMENT OUTCOME;

EID: 3142647046     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2004.02.002     Document Type: Letter

References (3)

1. Hollander E., Phillips A.T., Yeh C.C. Targeted treatments for symptom domains in child and adolescent autism. Lancet. 30:(362):2003;732-734
2. De Long G.R., Ritch C.R., Burch S. Fluoxetine response in children with autistic spectrum disorders Correlation with familial major affective disorder and intellectual achievement. Dev Med Child Neurol. 44:2002;652-659
3. Scahill L., Koenig K. Pharmacotherapy in children and adolescents with pervasive developmental disorders. Child Adolesc Psychiatr Nurs. 12:1999;41-43